Annual Shareholders Equity
$87.74 M
+$108.88 M+514.94%
31 December 2023
Summary:
Avadel Pharmaceuticals annual stockholders equity is currently $87.74 million, with the most recent change of +$108.88 million (+514.94%) on 31 December 2023. During the last 3 years, it has risen by +$9.49 million (+12.14%). AVDL annual shareholders equity is now -45.93% below its all-time high of $162.27 million, reached on 31 December 2020.AVDL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$74.66 M
+$4.38 M+6.22%
30 September 2024
Summary:
Avadel Pharmaceuticals quarterly stockholders equity is currently $74.66 million, with the most recent change of +$4.38 million (+6.22%) on 30 September 2024. Over the past year, it has dropped by -$13.08 million (-14.90%). AVDL quarterly shareholders equity is now -59.00% below its all-time high of $182.13 million, reached on 30 June 2020.AVDL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -14.9% |
| 3 y3 years | +12.1% | -4.6% |
| 5 y5 years | +400.5% | +355.7% |
AVDL Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +514.9% | -47.9% | +295.6% |
| 5 y | 5 years | -45.9% | +400.5% | -59.0% | +295.6% |
| alltime | all time | -45.9% | +400.5% | -59.0% | +295.6% |
Avadel Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $74.66 M(+6.2%) |
| June 2024 | - | $70.29 M(-10.3%) |
| Mar 2024 | - | $78.38 M(-10.7%) |
| Dec 2023 | $87.74 M(-514.9%) | $87.74 M(-20.3%) |
| Sept 2023 | - | $110.15 M(-23.1%) |
| June 2023 | - | $143.19 M(-475.2%) |
| Mar 2023 | - | -$38.17 M(+80.5%) |
| Dec 2022 | -$21.14 M(-127.0%) | -$21.14 M(+70.0%) |
| Sept 2022 | - | -$12.44 M(+273.3%) |
| June 2022 | - | -$3.33 M(-106.0%) |
| Mar 2022 | - | $55.23 M(-29.4%) |
| Dec 2021 | $78.24 M(-51.8%) | $78.24 M(-20.9%) |
| Sept 2021 | - | $98.96 M(-16.8%) |
| June 2021 | - | $118.88 M(-12.9%) |
| Mar 2021 | - | $136.50 M(-15.9%) |
| Dec 2020 | $162.27 M(-655.7%) | $162.27 M(-5.2%) |
| Sept 2020 | - | $171.20 M(-6.0%) |
| June 2020 | - | $182.13 M(+468.0%) |
| Mar 2020 | - | $32.07 M(-209.8%) |
| Dec 2019 | -$29.20 M(-1150.3%) | -$29.20 M(+8.3%) |
| Sept 2019 | - | -$26.96 M(+51.7%) |
| June 2019 | - | -$17.78 M(+85.5%) |
| Mar 2019 | - | -$9.58 M(-444.7%) |
| Dec 2018 | $2.78 M(-96.8%) | $2.78 M(-95.8%) |
| Sept 2018 | - | $65.74 M(-16.3%) |
| June 2018 | - | $78.55 M(-9.8%) |
| Mar 2018 | - | $87.05 M(+1.7%) |
| Dec 2017 | $85.58 M(+103.4%) | $85.58 M(-11.3%) |
| Sept 2017 | - | $96.46 M(+25.7%) |
| June 2017 | - | $76.73 M(+29.9%) |
| Mar 2017 | - | $59.08 M(+40.4%) |
| Dec 2016 | $42.07 M(-39.1%) | $42.07 M(+14.2%) |
| Sept 2016 | - | $36.83 M(-28.9%) |
| June 2016 | - | $51.84 M(-25.6%) |
| Mar 2016 | - | $69.70 M(+0.8%) |
| Dec 2015 | $69.13 M(+177.7%) | $69.13 M(+407.0%) |
| June 2015 | - | $13.64 M(-38.7%) |
| Mar 2015 | - | $22.25 M(-10.6%) |
| Dec 2014 | $24.89 M(-361.7%) | $24.89 M(-37.8%) |
| Sept 2014 | - | $40.05 M(-30.8%) |
| June 2014 | - | $57.86 M(-25.9%) |
| Mar 2014 | - | $78.13 M(-921.4%) |
| Dec 2013 | -$9.51 M(-131.2%) | -$9.51 M(-38.3%) |
| Sept 2013 | - | -$15.40 M(+53.1%) |
| June 2013 | - | -$10.06 M(-146.4%) |
| Mar 2013 | - | $21.68 M(-28.9%) |
| Dec 2012 | $30.50 M | $30.50 M(+20.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $25.36 M(-20.7%) |
| Mar 2012 | - | $31.98 M(+7.4%) |
| Dec 2011 | $29.79 M(-17.9%) | $29.79 M(-7.9%) |
| Sept 2011 | - | $32.36 M(+1.5%) |
| June 2011 | - | $31.89 M(-6.2%) |
| Mar 2011 | - | $34.02 M(-6.3%) |
| Dec 2010 | $36.30 M(-19.1%) | $36.30 M(+8.5%) |
| Sept 2010 | - | $33.47 M(+3.4%) |
| June 2010 | - | $32.36 M(-16.8%) |
| Mar 2010 | - | $38.91 M(-13.3%) |
| Dec 2009 | $44.86 M(-7.6%) | $44.86 M(-10.4%) |
| Sept 2009 | - | $50.07 M(+0.2%) |
| June 2009 | - | $49.95 M(+1.9%) |
| Mar 2009 | - | $49.04 M(+1.0%) |
| Dec 2008 | $48.55 M(-11.1%) | $48.55 M(-4.2%) |
| Sept 2008 | - | $50.66 M(-10.9%) |
| June 2008 | - | $56.86 M(-0.8%) |
| Mar 2008 | - | $57.32 M(+4.9%) |
| Dec 2007 | $54.63 M(-25.2%) | $54.63 M(-1.5%) |
| Sept 2007 | - | $55.43 M(-6.0%) |
| June 2007 | - | $58.98 M(-13.3%) |
| Mar 2007 | - | $68.02 M(-6.9%) |
| Dec 2006 | $73.03 M(-15.7%) | $73.03 M(+1.5%) |
| Sept 2006 | - | $71.92 M(-9.4%) |
| June 2006 | - | $79.37 M(-3.8%) |
| Mar 2006 | - | $82.50 M(-4.8%) |
| Dec 2005 | $86.65 M(-25.8%) | $86.65 M(-8.3%) |
| Sept 2005 | - | $94.53 M(-10.1%) |
| June 2005 | - | $105.11 M(-10.1%) |
| Mar 2005 | - | $116.95 M(+0.2%) |
| Dec 2004 | $116.76 M(+26.8%) | $116.76 M(+25.9%) |
| Sept 2004 | - | $92.77 M(0.0%) |
| June 2004 | - | $92.77 M(-1.3%) |
| Mar 2004 | - | $94.01 M(+2.1%) |
| Dec 2003 | $92.06 M(+649.3%) | $92.06 M(+349.5%) |
| Sept 2003 | - | $20.48 M(+92.5%) |
| June 2003 | - | $10.64 M(-3.9%) |
| Mar 2003 | - | $11.07 M(-9.9%) |
| Dec 2002 | $12.29 M(+63.6%) | $12.29 M(+2.7%) |
| Sept 2002 | - | $11.96 M(+59.2%) |
| Dec 2001 | $7.51 M(-31.0%) | $7.51 M(-31.0%) |
| Dec 2000 | $10.88 M(+20.0%) | $10.88 M(+20.0%) |
| Dec 1999 | $9.07 M(-49.0%) | $9.07 M(-49.0%) |
| Dec 1998 | $17.79 M(+24.4%) | $17.79 M(+56.0%) |
| Mar 1998 | - | $11.40 M(-20.3%) |
| Dec 1997 | $14.30 M(-38.1%) | $14.30 M(-38.1%) |
| Dec 1996 | $23.10 M | $23.10 M(-1640.0%) |
| Mar 1996 | - | -$1.50 M |
FAQ
- What is Avadel Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Avadel Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of AVDL is $87.74 M
What is the all time high annual shareholders equity for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual stockholders equity is $162.27 M
What is Avadel Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of AVDL is $74.66 M
What is the all time high quarterly shareholders equity for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly stockholders equity is $182.13 M
What is Avadel Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, AVDL quarterly stockholders equity has changed by -$13.08 M (-14.90%)